The trojan horse strategy in T-ALL therapy by engineering T-ALL-derived exosomes for targeted delivery of Isoliquiritigenin to the bone marrow to conquer Drug-Resistant T-ALL in PDX model - Yong Liu; Lindi Li; Cheng Ouyang; Zefan Du; Su Liu; Hailin Zou; Chunmou Li; Junbin Huang; Yucai Cheng; Mengyao Tian; Tianwen Li; Jiani Mo; et al. (Chemical Engineering Journal, 2025)